Machine learning based personalized drug response prediction for lung cancer patients
<div><p>Lung cancers with a mutated epidermal growth factor receptor (EGFR) are a major contributor to cancer fatalities globally. Targeted tyrosine kinase inhibitors (TKIs) have been developed against EGFR and show encouraging results for survival rate and quality of life. However, drug...
Saved in:
| Main Author: | Rizwan Qureshi (15279193) (author) |
|---|---|
| Other Authors: | Syed Abdullah Basit (18021787) (author), Jawwad A. Shamsi (14755778) (author), Xinqi Fan (735999) (author), Mehmood Nawaz (18418557) (author), Hong Yan (27984) (author), Tanvir Alam (638619) (author) |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computational Methods for the Analysis and Prediction of EGFR-Mutated Lung Cancer Drug Resistance: Recent Advances in Drug Design, Challenges and Future Prospects
by: Rizwan Qureshi (15279193)
Published: (2023) -
Leptomeningeal Metastatic L858R <i>EGFR</i>-mutant Lung Cancer: Prompt Response to Osimertinib in the Absence of T790M-mutation and Effective Subsequent Pulsed Erlotinib
by: Aladdin Kanbour (14442123)
Published: (2022) -
Lung-EffNet: Lung cancer classification using EfficientNet from CT-scan images
by: Rehan Raza (17019105)
Published: (2023) -
Predictive Model of Psychoactive Drugs Consumption using Classification Machine Learning Algorithms
by: Almahmood, Mothanna
Published: (2023) -
MMPatho: Leveraging Multilevel Consensus and Evolutionary Information for Enhanced Missense Mutation Pathogenic Prediction
by: Fang Ge (1533166)
Published: (2023)